These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31334208)

  • 1. Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls.
    Farhat N; Cools B; Gewillig M; Seghaye MC; Aggoun Y; Beghetti M
    Front Pediatr; 2019; 7():262. PubMed ID: 31334208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine.
    Shafie D; Dohaei A; Amin A; Taghavi S; Naderi N
    Res Cardiovasc Med; 2015 Nov; 4(4):e28945. PubMed ID: 26528452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.
    Milger K; Felix JF; Voswinckel R; Sommer N; Franco OH; Grimminger F; Reichenberger F; Seeger W; Ghofrani HA; Gall H
    Pulm Circ; 2015 Jun; 5(2):305-12. PubMed ID: 26064455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and survival of Korean idiopathic pulmonary arterial hypertension patients based on vasoreactivity.
    Ahn JH; Kang BJ; Hong SI; Lee JS; Lee JS; Oh YM; Lee SD
    J Korean Med Sci; 2014 Dec; 29(12):1665-71. PubMed ID: 25469067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.
    Jacheć W; Tomasik A; Kurzyna M; Pietura R; Torbicki A; Głowacki J; Nowalany-Kozielska E; Wojciechowska C
    BMC Pulm Med; 2019 Apr; 19(1):80. PubMed ID: 30991994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.
    Jonas K; Magoń W; Waligóra M; Seweryn M; Podolec P; Kopeć G
    Pol Arch Intern Med; 2018 Aug; 128(7-8):440-446. PubMed ID: 30057380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic study: indications for right- and left-sided catheterization in the diagnosis and follow-up of pulmonary hypertension].
    Amaro Cendón A
    Arch Bronconeumol; 2011; 47 Suppl 7():12-4. PubMed ID: 23351470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of a 37-year-old woman with pulmonary arterial hypertension first presented during her 3rd pregnancy and favourable long-term vasoreactive response.
    Westphal JG; Oehler M; Schulze PC; Kretzschmar D
    Eur Heart J Case Rep; 2022 Feb; 6(2):ytac031. PubMed ID: 35233488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report.
    Hirakawa K; Aoki T; Tsuji A; Ogo T
    Eur Heart J Case Rep; 2022 Sep; 6(9):ytac351. PubMed ID: 36072422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope.
    Linder AN; Hsia J; Krishnan SV; Rosenzweig EB; Krishnan US
    ERJ Open Res; 2022 Oct; 8(4):. PubMed ID: 36225331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome in a pregnant patient with idiopathic Pulmonary Arterial Hypertension: a case report and review of the literature.
    Rashidi F; Sate H
    J Med Case Rep; 2018 Feb; 12(1):31. PubMed ID: 29433561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricle performances with echocardiography and
    Liu J; Fei L; Huang GQ; Shang XK; Liu M; Pei ZJ; Zhang YX
    Exp Biol Med (Maywood); 2018 May; 243(9):754-761. PubMed ID: 29763366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of pediatric pulmonary hypertension with new guidelines.
    Kula S; Pektaş A
    Turk J Med Sci; 2017 Apr; 47(2):375-380. PubMed ID: 28425226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of acute pulmonary vasoreactivity test of sildenafil in treatment of portopulmonary hypertension. A case report.
    Akagi S; Nakamura K; Fuke S; Kusano KF; Ito H
    J Cardiol Cases; 2011 Aug; 4(1):e31-e33. PubMed ID: 30546711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
    Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
    Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
    Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.